3D Bioprinting in Medical Market By Products and solutions, By Technology, By Application, By End users : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "3D Bioprinting in Medical Market," The 3d bioprinting in medical market was valued at $1.1 billion in 2022, and is estimated to reach $4.9 billion by 2032, growing at a CAGR of 15.5% from 2023 to 2032.

However, high costs of bioprinters, lack of structured regulatory frameworks related to approvals for 3D bioprinters, copyright & patent infringement concerns, biocompatibility issues of 3D-bioprinted medical devices, and lack of technical expertise are the major factors hampering the growth of the market. Conversely, untapped markets in the developing countries are expected to provide lucrative opportunities for the market players.

The 3D bioprinting in medical market is segmented into products & solutions, technology, application, end user, and region. By products & solutions, the market is classified into bioprinters, consumables & accessories, and software & services. By technology, the market is classified into extrusion-based bioprinting, inkjet based bioprinting, laser assisted bioprinting, and others. By application, the market is segregated into tissue engineering & regenerative medicine, drug discovery & development, and others. By end user, the market is classified into biotechnology & pharmaceutical companies, academic & research institutes, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global 3D bioprinting in medical market are Organovo Holdings, Inc., Cyfuse Biomedical K.K., BICO, REGEMAT 3D, Desktop Metal, Inc., Medprin, Shining 3D, CollPlant Biotechnologies Ltd, Advanced Solutions, Inc., and 3D Systems Corporation. Key players operating in the market have adopted product launch, partnership, agreement, acquisition, collaboration, expansion, and product upgrade as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d bioprinting in medical market analysis from 2022 to 2032 to identify the prevailing 3d bioprinting in medical market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the 3d bioprinting in medical market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global 3d bioprinting in medical market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By End users

Biotechnology and pharmaceutical companies
Academic and research institutes
Others

By Products and solutions

Bioprinters
Consumables and accessories
Software and services

By Technology

Extrusion based bioprinting
Inkjet based bioprinting
Laser assisted bioprinting
Others

By Application

Tissue engineering and regenerative medicine
Drug discovery and development
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Cyfuse Biomedical K.K.
BICO
Desktop Metal, Inc.
Medprin
CollPlant Biotechnologies Ltd
3D Systems Corporation
Organovo Holdings, Inc.
REGEMAT 3D
Shining 3D
Advanced Solutions, Inc.

Product Code: A171553

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. High intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence of chronic diseases
  - 3.4.1.2. Surge in usage of 3D bioprinting in biomedical applications
  - 3.4.1.3. Advancements in 3D bioprinting
- 3.4.2. Restraints
  - 3.4.2.1. High cost associated with 3D printing
  - 3.4.2.2. Dearth of skilled professionals
- 3.4.3. Opportunities
  - 3.4.3.1. Growth opportunities in emerging markets
  - 3.4.3.2. Rise in pharmaceutical applications

CHAPTER 4: 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Bioprinters
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Consumables and accessories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Software and services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Extrusion based bioprinting
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Inkjet based bioprinting
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Laser assisted bioprinting
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Tissue engineering and regenerative medicine
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Drug discovery and development
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Biotechnology and pharmaceutical companies
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Academic and research institutes
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: 3D BIOPRINTING IN MEDICAL MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Products and solutions
- 8.2.3. Market size and forecast, by Technology
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End users
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by Products and solutions
  - 8.2.6.1.2. Market size and forecast, by Technology
  - 8.2.6.1.3. Market size and forecast, by Application
  - 8.2.6.1.4. Market size and forecast, by End users
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by Products and solutions
  - 8.2.6.2.2. Market size and forecast, by Technology
  - 8.2.6.2.3. Market size and forecast, by Application
  - 8.2.6.2.4. Market size and forecast, by End users
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by Products and solutions
  - 8.2.6.3.2. Market size and forecast, by Technology
  - 8.2.6.3.3. Market size and forecast, by Application
  - 8.2.6.3.4. Market size and forecast, by End users
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Products and solutions
- 8.3.3. Market size and forecast, by Technology
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End users
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by Products and solutions
  - 8.3.6.1.2. Market size and forecast, by Technology
  - 8.3.6.1.3. Market size and forecast, by Application
  - 8.3.6.1.4. Market size and forecast, by End users
  - 8.3.6.2. France
  - 8.3.6.2.1. Market size and forecast, by Products and solutions
  - 8.3.6.2.2. Market size and forecast, by Technology
  - 8.3.6.2.3. Market size and forecast, by Application
  - 8.3.6.2.4. Market size and forecast, by End users
  - 8.3.6.3. UK
  - 8.3.6.3.1. Market size and forecast, by Products and solutions
  - 8.3.6.3.2. Market size and forecast, by Technology
  - 8.3.6.3.3. Market size and forecast, by Application
  - 8.3.6.3.4. Market size and forecast, by End users
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Market size and forecast, by Products and solutions
  - 8.3.6.4.2. Market size and forecast, by Technology
  - 8.3.6.4.3. Market size and forecast, by Application
  - 8.3.6.4.4. Market size and forecast, by End users
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Market size and forecast, by Products and solutions
  - 8.3.6.5.2. Market size and forecast, by Technology
  - 8.3.6.5.3. Market size and forecast, by Application
  - 8.3.6.5.4. Market size and forecast, by End users
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by Products and solutions
  - 8.3.6.6.2. Market size and forecast, by Technology
  - 8.3.6.6.3. Market size and forecast, by Application
  - 8.3.6.6.4. Market size and forecast, by End users
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Products and solutions
- 8.4.3. Market size and forecast, by Technology
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End users
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Market size and forecast, by Products and solutions
  - 8.4.6.1.2. Market size and forecast, by Technology
  - 8.4.6.1.3. Market size and forecast, by Application
  - 8.4.6.1.4. Market size and forecast, by End users
  - 8.4.6.2. China
  - 8.4.6.2.1. Market size and forecast, by Products and solutions
  - 8.4.6.2.2. Market size and forecast, by Technology
  - 8.4.6.2.3. Market size and forecast, by Application
  - 8.4.6.2.4. Market size and forecast, by End users
  - 8.4.6.3. India
  - 8.4.6.3.1. Market size and forecast, by Products and solutions
  - 8.4.6.3.2. Market size and forecast, by Technology
  - 8.4.6.3.3. Market size and forecast, by Application
  - 8.4.6.3.4. Market size and forecast, by End users
  - 8.4.6.4. Australia
  - 8.4.6.4.1. Market size and forecast, by Products and solutions
  - 8.4.6.4.2. Market size and forecast, by Technology
  - 8.4.6.4.3. Market size and forecast, by Application
  - 8.4.6.4.4. Market size and forecast, by End users
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Market size and forecast, by Products and solutions
  - 8.4.6.5.2. Market size and forecast, by Technology
  - 8.4.6.5.3. Market size and forecast, by Application
  - 8.4.6.5.4. Market size and forecast, by End users
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by Products and solutions
  - 8.4.6.6.2. Market size and forecast, by Technology
  - 8.4.6.6.3. Market size and forecast, by Application
  - 8.4.6.6.4. Market size and forecast, by End users
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Products and solutions
- 8.5.3. Market size and forecast, by Technology
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End users
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by Products and solutions
  - 8.5.6.1.2. Market size and forecast, by Technology
  - 8.5.6.1.3. Market size and forecast, by Application
  - 8.5.6.1.4. Market size and forecast, by End users
  - 8.5.6.2. South Africa,
  - 8.5.6.2.1. Market size and forecast, by Products and solutions
  - 8.5.6.2.2. Market size and forecast, by Technology
  - 8.5.6.2.3. Market size and forecast, by Application
  - 8.5.6.2.4. Market size and forecast, by End users
  - 8.5.6.3. Saudi Arabia
  - 8.5.6.3.1. Market size and forecast, by Products and solutions
  - 8.5.6.3.2. Market size and forecast, by Technology
  - 8.5.6.3.3. Market size and forecast, by Application
  - 8.5.6.3.4. Market size and forecast, by End users
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Market size and forecast, by Products and solutions
  - 8.5.6.4.2. Market size and forecast, by Technology
  - 8.5.6.4.3. Market size and forecast, by Application
  - 8.5.6.4.4. Market size and forecast, by End users

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Advanced Solutions, Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Key strategic moves and developments
10.2. CollPlant Biotechnologies Ltd
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
10.3. Shining 3D
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
10.4. Organovo Holdings, Inc.
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
10.5. Medprin
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
10.6. Cyfuse Biomedical K.K.
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
10.7. Desktop Metal, Inc.
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. REGEMAT 3D
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
10.9. 3D Systems Corporation
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments
10.10. BICO
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments